Cargando…

A systematic review of the efficacy and safety of a purified, pasteurized C1 inhibitor concentrate for the treatment of patients with type I or II hereditary angioedema

Detalles Bibliográficos
Autores principales:	Bork, K, Steffense, I, Neme, A, Morrison, A, van den Hoef, G, Barnes, D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874303/ http://dx.doi.org/10.1186/1710-1492-6-S1-P32

Ejemplares similares

Case report of treatment with Icatibant for recurrent throat swelling due to hereditary angioedema
por: Chung, Arthur G, et al.
Publicado: (2010)

Acquired and hereditary forms of recurrent angioedema: Update of treatment
por: Bork, K.
Publicado: (2018)

74 Hereditary angioedema revealed by compartment syndrome
por: Boutrid, N, et al.
Publicado: (2022)

Recombinant and Plasma-Purified Human C1 Inhibitor for the Treatment of Hereditary Angioedema
por: Frank, Michael M
Publicado: (2010)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
por: Bork, Konrad
Publicado: (2010)

Hereditary angioedema
por: Lesser, Helen, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Patients with hereditary angioedema and patients with SARS-CoV-2-associated pneumonia – what can be similar?
por: Guryanova, Irina, et al.
Publicado: (2023)

Angioedema after ingestion of persimmon fruit
por: Shehu, E, et al.
Publicado: (2013)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2023)

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema
por: de Maat, Steven, et al.
Publicado: (2021)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema
por: Craig, Timothy, et al.
Publicado: (2017)

Efficacy of Treatment of Non-hereditary Angioedema
por: van den Elzen, Mignon, et al.
Publicado: (2016)

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
por: Tyson, Christopher, et al.
Publicado: (2019)

Hereditary angioedema in women
por: Bouillet, Laurence
Publicado: (2010)

Hereditary Angioedema: Not An Allergy
por: Bhivgade, Sanjay, et al.
Publicado: (2012)

The Pathophysiology of Hereditary Angioedema
por: Zuraw, Bruce L
Publicado: (2010)

Pediatric hereditary angioedema
por: MacGinnitie, Andrew J
Publicado: (2014)

Hereditary angioedema in childhood
por: Ahn, Young Min
Publicado: (2020)

Lanadelumab for hereditary angioedema
Publicado: (2022)

Biomarkers in Hereditary Angioedema
por: Porebski, Grzegorz, et al.
Publicado: (2021)

Fast 3: a phase III randomized double-blind, placebo-controlled multicenter study of Icatibant for subcutaneous injection in patients with acute Attacks of Hereditary Angioedema (HAE)
por: Ritchie, B
Publicado: (2010)

Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2
por: Fijen, Lauré M., et al.
Publicado: (2021)

The International/Canadian Hereditary Angioedema Guideline
por: Betschel, Stephen, et al.
Publicado: (2019)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

SISEA activities in Pasteur Institute in Nha Trang, Vietnam, during 2008–2009
por: Chien, Bui Trong, et al.
Publicado: (2011)

A dramatic case of non-episodic angioedema with eosinophilia
por: Clements-Baker, M, et al.
Publicado: (2010)

Adjunctive treatment of chronic idiopathic urticaria and angioedema with sulfasalazine
por: Pitt, T, et al.
Publicado: (2010)

453 A 26-Year Review of Long-term Safety of a Human Pasteurized C1 Inhibitor Concentrate
por: Bork, Konrad, et al.
Publicado: (2012)

Hereditary Angioedema Consensus 2010
por: Bowen, Tom
Publicado: (2010)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

The Search for Biomarkers in Hereditary Angioedema
por: Kaplan, Allen P., et al.
Publicado: (2017)

Improving the Management of Hereditary Angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2018)

Pediatric hereditary angioedema: an update
por: Sabharwal, Geetika, et al.
Publicado: (2017)

Are pediatricians familiar with hereditary angioedema?
por: Chong-Neto, Herberto José, et al.
Publicado: (2023)

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate
por: Zuraw, B. L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k9949r0vosisf5mc8jt774fdju